SREBF1 and Hepatic steatosis: Elevated levels of SREBP-1c and increased rates of DNL have been shown to be the primary drivers of hepatic steatosis in mouse models of insulin resistance (28), and elimination of SREBPs led to the resolution of hepatic steatosis mouse models of insulin resistance (27).